Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible?
C
C
Etherington
D G
DG
Peckham
S P
SP
Conway
M
M
Denton
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D019121:Burkholderia Infections / Q000175:diagnosis / Q000188:drug therapy*; D042602:Burkholderia cepacia complex / Q000187:drug effects* / Q000302:isolation & purification; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000382:microbiology*; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D018570:Risk Assessment; D012494:Sampling Studies; D055502:Secondary Prevention; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents